Financials
Financial year 2025
Herseltpharma from Herselt, company number BE0892542332, closed financial year 2025 with a result of € 268,806 after tax. For that financial year Herseltpharma recorded a gross margin of € 821,455 and equity of € 920,049. Compared with financial year 2024, the result moved from € 95,906 to € 268,806. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 920,049
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 268,806
▲ 180% vs 2024
Profit after tax over the fiscal year.
€ 110,889
▲ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 136,717 paid out
51 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
3.7
Average over the fiscal year, from the social balance sheet.
€ 243,487
▲ 18% vs 2024
€ 65,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,207
▼ 42% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 193,340
▼ 33% vs 2024
€ 94,784 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 119,534
▼ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 63,151
▲ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 449,096 | € 506,814 | € 563,105 | € 821,455 | ▲ 46% |
| Profit after taxes | € 84,957 | € 130,178 | € 95,906 | € 268,806 | ▲ 180% |
| Equity | € 617,554 | € 692,055 | € 787,961 | € 920,049 | ▲ 17% |
| Total debts | € 888,260 | € 879,979 | € 739,669 | € 391,907 | ▼ 47% |
| Cash | € 93,041 | € 205,491 | € 107,792 | € 110,889 | ▲ 3% |
| Land & buildings | € 70,470 | € 63,417 | € 56,363 | - | |
| Retained profit | € 553,954 | € 628,455 | € 724,361 | € 856,449 | ▲ 18% |
| Dividend | € 0 | € 55,677 | € 0 | € 136,717 | |
| Bank debt | € 481,203 | € 386,867 | € 290,444 | € 193,340 | ▼ 33% |
| Balance sheet total | € 1,505,813 | € 1,572,034 | € 1,527,630 | € 1,311,956 | ▼ 14% |
| Employees (FTE) | 3.6 | 3.5 | 3.7 | 3.7 |
By gross margin, Herseltpharma ranks 19th of 545 companies with main activity “Detailhandel in farmaceutische producten” in the province of Antwerp that publish figures (fiscal year 2025).
Key figures of Herseltpharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Herseltpharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Herseltpharma?
What happened at Herseltpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 268,806 (▲ 180% vs 2024). Source: NBB ↗
- New establishment in Herselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 84,957 profit in 2022 to € 268,806 profit in 2025.
Paid € 291,907 in corporate taxes since 2022.
Best year ever: 2025, with € 268,806 profit.
On average € 222,000 of value added per employee in 2025.
Management
Behind Herseltpharma is Kathleen Gielis. Kathleen Gielis is also behind MIJN APOTHEEK.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Dorp 50
2230 Herselt
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in the province of Antwerp
Same main activity (Detailhandel in farmaceutische producten), 620 active companies in the province of Antwerp, largest first.
€ 65.6 million revenue · 2024 · Kontich
€ 16.2 million revenue · 2025 · Malle
€ 13 million revenue · 2025 · Wuustwezel
€ 9 million revenue · 2025 · Antwerpen
€ 2.5 million gross margin · 2025 · Ranst
€ 2.4 million gross margin · 2025 · Ranst
Details
- Company number
- 0892.542.332
- VAT number
- BE 0892.542.332
- Registered office
- Dorp 50, 2230 Herselt
- Names & denominations
- Herseltpharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 October 2007
- Peppol
- Active · Active since 27 Jun 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings